Aktar Mert
SEC insider (Form 3/4/5 filer). CIK 0002040256. Director at Kyverna Therapeutics, Inc. (KYTX). 3 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in EMERYVILLE, CA.
Companies Aktar Mert has filed insider reports for
- Kyverna Therapeutics, Inc. (KYTX): Director
Aktar Mert
CIK: 0002040256
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYTX
Kyverna Therapeutics, Inc.
Director